Autonomous, IoT-Enabled Cold-Chain Ground Support Equipment (GSE) Eliminates Tarmac Thermal Excursions for High-Value Pharmaceuticals, APIs, and Perishables at IGI Airport


NEW DELHI — Air India SATS Airport Services (AISATS), a joint venture gateway services provider, has operationalized India’s first fleet of purpose-built, high-velocity temperature-controlled air cargo pods across the airside cargo aprons of Indira Gandhi International (IGI) Airport, New Delhi.

The next-generation ground-support fleet is engineered to seal the historical "tarmac thermal gap"—the high-risk transition window when sensitive cargo moves across exposed aprons between climate-controlled airport freight terminals and widebody aircraft cargo holds.

Equipped with smart telemetry, active multi-zone cooling compressors, and autonomous tug-docking interfaces, the fleet ensures uninterrupted cold-chain integrity across ambient tarmac surface temperatures that regularly exceed 45°C during peak operating hours. The rollout directly strengthens India’s air-export corridor for Active Pharmaceutical Ingredients (APIs), biologicals, vaccines, clinical trial samples, and high-value perishable horticulture bound for regulated markets across North America, Europe, and the Middle East.

Closing the Critical "Last 500 Metres" Tarmac Exposure Vulnerability

While modern air freight terminals and modern widebody aircraft feature sophisticated climate-controlled storage zones, the physical movement of cargo across the open apron has long been the primary point of failure for temperature-sensitive shipments:

  • Thermal Shock Risk: Palletized pharmaceuticals wrapped in thermal blankets often sit exposed during pushback delays, runway crossings, and aircraft hold-loading cycles. Ambient radiant heat from airport asphalt can trigger rapid temperature spikes, risking product spoilage and regulatory rejection.

  • Strict Regulatory Mandates: International compliance standards—including the World Health Organization’s Good Distribution Practices (WHO-GDP) and the European Medicines Agency (EMA) guidelines—require unbroken, auditable temperature logs across the entire multimodal transit lifecycle.

  • High Commercial Value at Risk: A single airline cargo container (Unit Load Device, or ULD) of oncology medicines, monoclonal antibodies, or temperature-critical biopharmaceuticals can exceed several million dollars in commercial value, making zero thermal excursion an operational necessity for air carriers and freight forwarders.

The AISATS pod fleet eliminates these vulnerabilities by encasing cargo within a mobile, actively refrigerated micro-climate from the moment it leaves the terminal’s cool-storage staging docks until it is hoisted into the aircraft hold.

Boosting India's Life-Sciences Export Velocity

The deployment at Delhi Airport—India’s largest air cargo hub by volume—provides critical infrastructure support for the country’s growing pharmaceutical export engine:

  • Pharma Corridor Reliability: Northern India’s pharmaceutical manufacturing clusters in Baddi, Paonta Sahib, Haridwar, and Gurugram rely heavily on Delhi Airport as their primary global export gateway. The cold-chain pods provide these manufacturers with end-to-end GDP compliance verification.

  • Accelerated Aircraft Turnarounds: The motorized, high-velocity pods feature rapid coupling systems that allow airport ground crews to transfer temperature-sensitive ULDs onto aircraft high-loaders 30% faster than conventional tractor-trolley assemblies, compressing flight ground turnaround times.

  • Perishable Protection: In addition to healthcare cargo, the pods handle high-value perishables—such as exotic fruits, cut flowers, and fresh meat exports—preventing shelf-life degradation before departure to the Gulf and Southeast Asian consumer hubs.

Industry and Executive Statements

Speaking on the airside deployment at Terminal 3 Cargo City, executive leadership from AISATS stated:

"The introduction of this specialized temperature-controlled pod fleet marks a paradigm shift in Indian airside ground logistics. For decades, the industry relied on passive covers and rushed tarmac transfers to protect critical pharmaceutical consignments. With this fleet, Delhi Airport offers an unbroken, active cold chain from warehouse intake straight to the aircraft hold. This operational capability cements Delhi’s position as a premier global transshipment hub for sensitive life-sciences cargo, aligning our ground infrastructure with the most stringent global standards."

AISATS confirmed that the initial deployment of 25 active cold-chain pods will be expanded across other key Indian stations within its network, including Bengaluru, Hyderabad, and the upcoming Multi-Modal Cargo Hub at Noida International Airport, through early 2027.